Related references
Note: Only part of the references are listed.Microinflammation Factors in the Common Diseases of the Heart and Kidneys
Danijela Tasic et al.
DISEASE MARKERS (2015)
Combined oral contraceptive synergistically activates mineralocorticoid receptor through histone code modifications
Adedoyin Igunnu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Role of Plasminogen Activator Inhibitor-1 in Glucocorticoid-Induced Diabetes and Osteopenia in Mice
Yukinori Tamura et al.
DIABETES (2015)
Cross-talk between mineralocorticoid receptor/angiotensin II type 1 receptor and mitogen-activated protein kinase pathways underlies aldosterone-induced atrial fibrotic responses in HL-1 cardiomyocytes
Chin-Feng Tsai et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
The role of the renin-angiotensin system in the development of insulin resistance in skeletal muscle
Erik J. Henriksen et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
Metabolic actions of angiotensin II and insulin: A microvascular endothelial balancing act
Ranganath Muniyappa et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
The renin-angiotensin system: a target of and contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndrome
Kelly Putnam et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2012)
Effects of Estrogen on Cardiovascular Injury in Ovariectomized Female DahlS.Z-Leprfa/Leprfa Rats as a New Animal Model of Metabolic Syndrome
Tamayo Murase et al.
HYPERTENSION (2012)
Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury
James M. Luther et al.
KIDNEY INTERNATIONAL (2012)
Plasminogen activator inhibitor-1 deficient mice are protected from angiotensin II-induced fibrosis
Juliane I. Beier et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2011)
Angiotensin III Stimulates Aldosterone Secretion from Adrenal Gland Partially via Angiotensin II Type 2 Receptor But Not Angiotensin II Type 1 Receptor
Junichi Yatabe et al.
ENDOCRINOLOGY (2011)
Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in comparison to one containing levonorgestrel and ethinylestradiol on markers of endocrine function
Ulla M. Agren et al.
EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE (2011)
Aldosterone Perturbs Adiponectin and PAI-1 Expression and Secretion in 3T3-L1 Adipocytes
P. Li et al.
HORMONE AND METABOLIC RESEARCH (2011)
Dyslipidaemia, combined oral contraceptives use and their interaction on the risk of hypertension in Chinese women
W. Wei et al.
JOURNAL OF HUMAN HYPERTENSION (2011)
PREVALENCE OF METABOLIC SYNDROME IN AN ELDERLY CHINESE POPULATION: A COMMUNITY-BASED CROSS-SECTIONAL STUDY
Wang BinYou et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2010)
Effect of Valsartan on the Incidence of Diabetes and Cardiovascular Events
John J. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity
K. G. M. M. Alberti et al.
CIRCULATION (2009)
The effects of two monophasic oral contraceptives containing 30 mcg of ethinyl estradiol and either 2 mg of chlormadinone acetate or 0.15 mg of desogestrel on lipid, hormone and metabolic parameters
Ulrich H. Winkler et al.
CONTRACEPTION (2009)
Endogenous Aldosterone Contributes to Acute Angiotensin II-Stimulated Plasminogen Activator Inhibitor-1 and Preproendothelin-1 Expression in Heart But Not Aorta
James M. Luther et al.
ENDOCRINOLOGY (2009)
Daily variation of brain-derived neurotrophic factor and cortisol in women with normal menstrual cycles, undergoing oral contraception and in postmenopause
N. Pluchino et al.
HUMAN REPRODUCTION (2009)
Estradiol increases angiotensin II type 1 receptor in hearts of ovariectomized rats
Vincent Ricchiuti et al.
JOURNAL OF ENDOCRINOLOGY (2009)
Effect of the angiotensin receptor blocker irbesartan on metabolic parameters in clinical practice:: the DO-IT prospective observational study
Klaus G. Parhofer et al.
CARDIOVASCULAR DIABETOLOGY (2007)
Angiotensin II-mediated protein kinase D activation stimulates aldosterone and cortisol secretion in H295R human adrenocortical cells
Damian G. Romero et al.
ENDOCRINOLOGY (2006)
Estradiol increases proteinuria and angiotensin II type 1 receptor in kidneys of rats receiving L-NAME and angiotensin II
E. M. Oestreicher et al.
KIDNEY INTERNATIONAL (2006)
Plasminogen activator inhibitor-1 in chronic kidney disease: Evidence and mechanisms of action
Allison A. Eddy et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Fibrinolytic response to exercise in women using third-generation oral contraceptives
Claus Weiss et al.
BLOOD COAGULATION & FIBRINOLYSIS (2006)
PAI-1 and the metabolic syndrome - Links, causes, and consequences
Marie-Christine Alessi et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Contributions of β-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose
MA Abdul-Ghani et al.
DIABETES CARE (2006)
Oral contraceptives and the management of hyperandrogenism-polycystic ovary syndrome in adolescents
PJA Hillard
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2005)
Glucose metabolism and coronary heart disease in patients with normal glucose tolerance
FC Sasso et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Clinical and metabolic aspects of the continuous use of a contraceptive association of ethinyl estradiol (30 μg) and gestodene (75 μg)
RB Machado et al.
CONTRACEPTION (2004)
Estrogen promotes microvascular pathology in female stroke-prone spontaneously hypertensive rats
CT Stier et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2003)
Angiotensin converting enzyme inhibitors and modulation of skeletal muscle insulin resistance
EJ Henriksen et al.
DIABETES OBESITY & METABOLISM (2003)
Mechanisms involved in the side effects of glucocorticoids
H Schäcke et al.
PHARMACOLOGY & THERAPEUTICS (2002)
Effects of hormone replacement therapy and estrogen receptor modulators on markers of inflammation and coagulation
M Cushman
AMERICAN JOURNAL OF CARDIOLOGY (2002)
Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis
JR Jonsson et al.
GASTROENTEROLOGY (2001)
Share Paper
